Wedbush Starts Aravive Inc. (ARAV) at Outperform
- Wall Street comes off record highs ahead of big tech earnings
- Tesla (TSLA) Gains on Q2 Beat, Analysts Mostly Positive but Others Cautious
- China's Meituan (MPNGF) Plunges 17.6% to Push Hang Seng Index to 8-Month Lows as Heavy Selling Continues
- Dollar eases slightly with Fed in focus
- Elon Musk Laid Into Apple (AAPL) During Tesla's (TSLA) Q2 Earnings Call
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
Wedbush analyst David Nierengarten initiates coverage on Aravive Inc. (NASDAQ: ARAV) with a Outperform rating and a price target of $14.00.
Shares of Aravive Inc. closed at $6.97 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aravive to Participate in Fireside Chat at 2021 BTIG Biotechnology Conference
- UPDATE: Jefferies Starts POINT Biopharma Global Inc. (PNT) at Hold
- UPDATE: Ladenburg Thalmann Starts electroCore Inc. (ECOR) at Buy
Create E-mail Alert Related CategoriesNew Coverage
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!